Treating psoriasis to prevent heart attacks and strokes
A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could ...
Diseases, Conditions, Syndromes
Mar 16, 2012 |
not rated yet |
0
UVB preferred for treatment of moderate to severe psoriasis
(HealthDay) -- Ultraviolet B (UVB) is preferred by dermatologists for first-line treatment of moderate to severe psoriasis in both healthy male and female patients, according to a study published in the March ...
Diseases, Conditions, Syndromes
Feb 24, 2012 |
not rated yet |
0
Biological agents for rheumatoid arthritis associated with increased skin cancer risk
Biological agents used to treat rheumatoid arthritis seem to be associated with an increased risk of skin cancer, indicates a systematic review of published research in the Annals of the Rheumatic Diseases.
Cancer
Sep 08, 2011 |
3 / 5 (2) |
0
Targeted adalimumab treatment can optimize long-term outcomes for patients with early RA
Data presented today at the EULAR 2011 Annual Congress demonstrated that initial treatment with adalimumab (Humira, ADA) plus methotrexate in early RA patients can provide high levels of disease control in many patients, ...
Diseases, Conditions, Syndromes
May 25, 2011 |
not rated yet |
0
Adalimumab levels detected in cord blood and infants exposed in utero
Adalimumab (ADA), a drug often prescribed for women with Crohn's disease, actively crosses the placenta during the final trimester of pregnancy and remains in a newborn's bloodstream for at least three months, researchers ...
Medications
May 08, 2011 |
not rated yet |
0
- Pages: 1 2
